Many lesions are located in blind spots
One cause of missed lesions is incomplete visualisation of the entire colon5
Most missed lesions are located behind folds, out of view of standard colonoscopy1
The adenoma and polyp miss rates with standard colonoscopy have been reported to be 24% and 41%, respectively6,7
The hinged arms of ENDOCUFF VISION® extend to gently flatten large mucosal folds, allowing clear visualisation of the colon mucosa
ENDOCUFF VISION® can increase ADR
In the overall population (n=1,772) ENDOCUFF VISION® achieved a 4.7% absolute improvement (p<0.02) in ADR vs standard colonoscopy (13% relative improvement)*2
Even better results were seen in the Bowel Cancer Screening Programme (BCSP) population (n=797) with a 10.8% absolute improvement (p<0.001) in ADR vs standard colonoscopy (21% relative improvement)2
Other studies have reported absolute improvements in ADR of up to 16% with ENDOCUFF VISION®†5,8
The cancer detection rate was significantly higher with ENDOCUFF VISION® assisted colonoscopy vs. standard colonoscopy in the overall population (4.1% vs. 2.3%, respectively; p=0.03)*2
In the BCSP population, the cancer detection rate was also significantly higher compared with standard colonoscopy (6.6% vs. 3.7%, respectively; p=0.03)2
Click here to read the full paper in Gut
Adapted from Ngu et al 2018.2
*The overall population included all patients in the BCSP population plus all non-BCSP patients. †One study was conducted using ENDOCUFFTM, an earlier version of the current device, ENDOCUFF VISION®.
Increasing your ADR may reduce the risk of Interval CRC3,4
Every 1% increase in ADR is associated with a 3% decrease in the risk of interval CRC, and 5% decrease in the risk of fatal CRC3
Endoscopists who increased their ADR during screening colonoscopies significantly reduced the risk of their patients developing interval and fatal CRC (p=0.006 and p=0.035, respectively)4
- Pickhardt PJ, et al. Ann Intern Med 2004; 141(5): 352-359.
- Ngu WS, et al. Gut 2018; 66: 1–9.
- Corley DA, et al. N Engl J Med 2014; 370(14): 1298-1306.
- Kaminski MF, et al. Gastroenterology 2017; 153(1): 98-105.
- De Palma GD, et al. Gastrointest Endosc 2018; 87(1): 232-240.
- Rex DK, et al. Gastroenterology 1997; 112(1): 24-28.
- Gralnek IM, et al. Lancet Oncol 2014; 15(3): 353-360.
- Tsiamoulos ZP, et al. Gastrointest Endosc 2018; 87(1): 280-287.